The Ahmedabad-based drug firm says the treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials
Read more here:: Post India Listing
Follow Our Network On LinkedIn: Follow link
Search India recent news in rumors and anything online listing
The Ahmedabad-based drug firm says the treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials
Read more here:: Post India Listing